Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: A pharmacogenetic assessment of outcome and toxicity

William D. Figg^*, Cindy H. Chau, Ravi A. Madan, James L. Gulley, Rui Gao, Tristan M. Sissung, Shawn Spencer, Melony Beatson, Jeanny Aragon-Ching, Seth M. Steinberg, William L. Dahut

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review